Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Submitted by
admin
on February 29, 2012 - 10:12am
Source:
Bloomberg
News Tags:
obesity
M&A
Vivus
Qnexa
JNJ
Merck
Bristol-Myers Squibb
Arena Pharmaceuticals
Orexigen
Headline:
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Do Not Allow Advertisers to Use My Personal information
